Position in AZN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$7,015
New position
Shares Held
37
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,395
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHESAPEAKE ASSET MANAGEMENT LLC holds $16,421,292 across 10 Drug Manufacturers - General names. AZN ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,659 | $11,585,295 | |
| 2 | MRK |
Merck & Co., Inc.
|
15,999 | $2,055,871 | |
| 3 | ABBV |
AbbVie Inc.
|
5,763 | $1,450,201 | |
| 4 | JNJ |
Johnson & Johnson
|
4,549 | $1,155,309 | |
| 5 | PFE |
Pfizer Inc
|
4,008 | $96,512 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
972 | $56,006 | |
| 7 | GSK |
GSK plc
|
248 | $13,000 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
37 | $7,015 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,015 | 37 | Shares | Sole | 2026-08-04 | |
| No filing history on record for this holder in this stock. | ||||||